Research Article
[Retracted] FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
Figure 3
Survival outcome, expression difference analyzed by GEPIA, and multivariate Cox analysis of FLG: (a) differential expression of FLG in different disease state (tumor and normal); (b) survival curve of differential FLG expression; (c) differential expression of FLG in different pathological stages; (d) the expression of FLG and multivariate Cox analysis of clinicopathological factors.
| (a) |
| (b) |
| (c) |
| (d) |